Business
Nanalysis Scientific Corp. Closes Bought Deal Public Offering and Concurrent Non-Brokered Private Placement for Gross Proceeds of C$10,997,686
Nanalysis Scientific Corp. Closes Bought Deal Public Offering and Concurrent Non-Brokered...
About this update from Nanalysis Scientific Corp
[{"type":"text","content":"\n \n \n \n Nanalysis Scientific Corp. Closes Bought Deal Public Offering and Concurrent Non-Brokered Private Placement for Gross Proceeds of C$10,997,686\n \n \n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n \n \n \n \n \n \n Canada NewsWire\n \n \n \n \n \n CALGARY, AB\n \n ,\n \n Aug. 25, 2021\n \n /CNW/ - Nanalysis Scientific Corp.\n \n Nanalysis Scientific Corp.\n \n (\"the Company\"), (\n \n TSXV: NSCI\n \n ) (\n \n OTCQX: NSCIF\n \n ) (\n \n FRA: 1N1\n \n ), announces it has closed the previously-announced underwritten public offering (the \"Public Offering\") of units (the \"Units\") of the Company and the concurrent non-brokered private placement of Units (the \"Private Placement\") for combined gross proceeds of\n \n C$10,997,686.40\n \n .\n \n \n \n \n \n \n \n \n \n Pursuant to the terms of the Public Offering, the Company issued 7,666,706 Units, including 1,000,006 Units issued pursuant to the exercise of the Underwriters' over-allotment option, at a price per Unit of\n \n C$1.20\n \n for aggregate gross proceeds of\n \n C$9,200,047.20\n \n . Each Unit consists of one common share (each a \"Common Share\") and one-half of one common share purchase warrant of the Company (each whole common share purchase warrant, a \"Warrant\"). Each Warrant is exercisable to acquire one Common Share of the Company at an exercise price of\n \n C$1.70\n \n per Warrant until\n \n August 25, 2023\n \n , subject to adjustment in certain events.\n \n \n Echelon Wealth Partners Inc., as lead underwriter and sole bookrunner, along with Leede Jones Gable Inc. acted as the underwriters for the Public Offering.\n \n \n A total of 1,498,032 Units were issued pursuant to the Private Placement at a price of\n \n C$1.20\n \n per Unit for gross proceeds to the Company of\n \n C$1,797,639.20\n \n . Each Unit issued pursuant to the Private Placement consists of one Common Share and one-half of one Warrant. Each Warrant is exercisable to acquire one common share of the Company at an exercise price of\n \n C$1.70\n \n per Warrant until\n \n August 25, 2023\n \n , subject to adjustment in certain event...